|Description||JWH 133 is a synthetic cannabinoid and acts as a potent CB2 selective agonist with Ki value of 3.4 nM. It is used to synthesize CB2-selective cannabinoid receptor ligands. It is active in vivo and reduces spasticity in a murine model of multiple sclerosis.|
|Purity||≥98% by HPLC|
|Synonyms||JWH-133; JWH 133; JWH133. (6aR,10aR)-3-(1,1-Dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; 3-(1,1-dimethylbutyl)-6aR,7,10,10aR-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran|
LEI 101 hydrochloride is a CB2 partial agonist with pEC50 value of 8.0. It shows antinociceptive activity in a rat neuropathic pain model. LEI 101 hydrochloride...
Arvanil is a vanilloid TRPV1 (VR1) and cannabinoid CB1 agonist with Ki values of 0.3 and 0.5 μM respectively. It increases lung tidal volume, diaphragm activity...
LY 320135 is a selective CB1 receptor antagonist.
Org 27569 is an allosteric modulator of cannabinoid CB1 receptor, induces a CB1 receptor state that is characterized by enhanced agonist affinity and decreased ...
AM 1714, a synthetic cannabimimetic indole derivative, is a potent and selective agonist for the cannabinoid receptor.
Tocrifluor T1117 is a fluorescent analog of AM 251, which is a GPR55 agonist and CB1 receptor antagonist. AM 251 conjugated with 5-carboxytetramethylrhodamine (...
Leelamine, a diterpene molecule, has weak affinity for the human central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. Leelamine is also a PDK(p...
MJ 15 is a CB1 receptor antagonist with IC50 value of 118.9 pM for rat CB1 receptors. It can inhibit food intake and increase body weight in diet-induced obese ...